Skip to main content
Clinical Trials/NCT04280861
NCT04280861
Unknown
N/A

Multicomponent Intervention in Caregivers on Quality of Life of People With Dementia: a Clinical Trial

Consorci Hospitalari de Vic1 site in 1 country94 target enrollmentFebruary 2, 2020

Overview

Phase
N/A
Intervention
Not specified
Conditions
Alzheimer Disease
Sponsor
Consorci Hospitalari de Vic
Enrollment
94
Locations
1
Primary Endpoint
Changes in quality of life of the patients after intervention and 6 months follow-up in control and intervention group: Quality of Life-Alzheimer's Disease (QoL-AD)
Last Updated
6 years ago

Overview

Brief Summary

The main objective is to determine the effectiveness of a multicomponent intervention for caregivers, conducted by an expert psychologist to improve the quality of life of the people with Alzheimer's disease. Secondarily, will be analyzed the effectiveness of this program on improving anxiety and depressive symptoms, burden, happiness, social support and cognitive performance of the caregivers and alleviate the behavioural and psychological symptoms of dementia (BPSD). The investigators analyze the caregiver's and patient's personality as a possible moderator between dependent and independent variables, and the resources utilization before and after intervention.

Methods: randomized study with parallel assignment in two groups: control and intervention group, six-month follow-up. The eligible participants will be 94 adult (≥18 years) caregivers of patients with Alzheimer's disease who follow-up by Osona Integrated Geriatric Unite (Catalonia, Spain).

The intervention group will receive a multicomponent intervention that includes dementia psychoeducation and management, emotional and communication skills, mindfulness and healthy lifestyle. The control group will follow the standard management according to the primary and specialized care professionals' team.

Main measurements: quality of life of the patients at baseline, after intervention and at six-month follow-up through QoL-AD. Secondary measures: they will be determined, at baseline, after the intervention and at six-month follow-up: depression (HDRS) and anxiety (HARS), burden (CBI), happiness (OHQ), quality of life (QoL-AD), social support (UCLA and DUKE-ANC), cognitive performance (neuropsychological assessment) of the caregivers, resources utilization (RUD), BPSD (NPI), cognitive status (MMSE), functional status (IADL) of the patients. Caregiver's personality at baseline and six-month follow-up and dementia characteristics at baseline will be measured. Other measures: sociodemographic and health characteristics of the caregivers and patients.

Registry
clinicaltrials.gov
Start Date
February 2, 2020
End Date
December 21, 2021
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Dr. Pere Roura-Poch

Head of Epidemiology

Consorci Hospitalari de Vic

Eligibility Criteria

Inclusion Criteria

  • adults (≥18 years of age)
  • main caregivers of people with early or mild Alzheimer's disease
  • follow-up by Osona Integrated Geriatric Unite (Catalonia)
  • signed informed consent.

Exclusion Criteria

  • non stable medical condition the last six months (or any acute or chronic condition that would limit the ability of the patient to participate in the study)
  • cognitive impairment (MMSE\<24)
  • substance abuse
  • active psychotherapy
  • refusal to give informed consent

Outcomes

Primary Outcomes

Changes in quality of life of the patients after intervention and 6 months follow-up in control and intervention group: Quality of Life-Alzheimer's Disease (QoL-AD)

Time Frame: Baseline, immediately after the intervention and 6 month follow-up

Quality of life assessed using Quality of Life-Alzheimer's Disease (QoL-AD). The total score ranges from 13 to 52, with a higher number indicating better quality of life

Secondary Outcomes

  • Satisfaction with the intervention: Interview(Immediately after the intervention)
  • Changes in quality of life of the caregivers: Quality of Life-Alzheimer's Disease (QoL-AD)(Baseline, immediately after the intervention and 6 month follow-up)
  • Changes in loneliness(Baseline, immediately after the intervention and 6 month follow-up)
  • Characteristics and changes in caregivers personality(Baseline, immediately after the intervention and 6 month follow-up)
  • Changes in Behavioural and Psychological Symptoms of Dementia(Baseline, immediately after the intervention and 6 month follow-up)
  • Burden in caregivers(Baseline, immediately after the intervention and 6 month follow-up)
  • Changes in depression of the caregivers(Baseline, immediately after the intervention and 6 month follow-up)
  • Changes in cognitive performance of the caregivers(Baseline, immediately after the intervention and 6 month follow-up)
  • Changes in sleep patterns of the caregivers(Baseline, immediately after the intervention and 6 month follow-up)
  • Changes of the resource utilization(Baseline, immediately after the intervention and 6 month follow-up)
  • Changes in cognitive status of the patients(Baseline, immediately after the intervention and 6 month follow-up)
  • Anxiety(Baseline, immediately after the intervention and 6 month follow-up)
  • Happiness(Baseline, immediately after the intervention and 6 month follow-up)
  • Changes in perceived social support of the caregivers(Baseline, immediately after the intervention and 6 month follow-up)
  • Functional status of the patients(Baseline, immediately after the intervention and 6 month follow-up)

Study Sites (1)

Loading locations...

Similar Trials